AI Assistant
Blog
Pricing
Log In
Sign Up
A good marker does not mean a good target for clinical trials in Alzheimer's disease: the amyloid hypothesis questioned
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
